Thomas Knappe
8Patents
1h-index
12Co-inventors
44Inventor score
Filing activity: Oct 8, 2013 → Mar 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10519226B2 | VEGF neutralizing prodrugs for the treatment of ocular conditions | Chemistry; Metallurgy | 5 | Active |
| US11642415B2 | Hydrogel cross-linked hyaluronic acid prodrug compositions and methods | Human Necessities | 1 | Active |
| US9855340B2 | Hydrogel prodrugs | Chemistry; Metallurgy | 1 | Active |
| US10040850B2 | Protecting group comprising a purification tag | Emerging Cross-Sectional Technologies | 0 | Active |
| US12246070B2 | Hydrogel cross-linked hyaluronic acid prodrug compositions and methods | Human Necessities | 0 | Active |
| US10653795B2 | Hydrogel-linked prodrugs releasing tagged drugs | General | 0 | Revoked |
| US11116849B2 | Hydrogel-linked prodrugs releasing tagged drugs | Human Necessities | 0 | Active |
| US11633487B2 | Prodrugs comprising an aminoalkyl glycine linker | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.